Alivus Life Sciences has announced a board meeting on November 06, 2025, to review and approve the unaudited financial results for the quarter and half-year ending September 30, 2025. The company has also announced the closure of the Trading Window for designated persons from September 30, 2025, to November 08, 2025, inclusive, in connection with this board meeting.
Board Meeting Announcement
Alivus Life Sciences is set to hold a meeting of its Board of Directors on November 06, 2025. The primary agenda of this meeting is to consider and approve the unaudited financial results for the quarter and half-year that concluded on September 30, 2025.
Trading Window Closure
In line with company policy, Alivus Life Sciences has announced the closure of its trading window. This restriction applies to the company’s designated persons and will be in effect from September 30, 2025, until November 08, 2025. The closure is directly linked to the impending approval of the unaudited financial results for the period ending September 30, 2025.
Source: BSE
